The potential renal toxicity of silver nanoparticles after repeated oral exposure and its underlying mechanisms

BMC Nephrol. 2021 Jun 18;22(1):228. doi: 10.1186/s12882-021-02428-5.

Abstract

Background: Silver nanoparticles (AgNPs) can accumulate in various organs after oral exposure. The main objective of the current study is to evaluate the renal toxicity induced by AgNPs after repeated oral exposure and to determine the relevant molecular mechanisms.

Methods: In this study, 40 male Wistar rats were treated with solutions containing 30, 125, 300, and 700 mg/kg of AgNPs. After 28 days of exposure, histopathological changes were assessed using hematoxylin-eosin (H&E), Masson's trichrome, and periodic acid-Schiff (PAS) staining. Apoptosis was quantified by TUNEL and immunohistochemistry of caspase-3, and the level of expression of the mRNAs of growth factors was determined using RT-PCR.

Results: Histopathologic examination revealed degenerative changes in the glomeruli, loss of tubular architecture, loss of brush border, and interrupted tubular basal laminae. These changes were more noticeable in groups treated with 30 and 125 mg/kg. The collagen intensity increased in the group treated with 30 mg/kg in both the cortex and the medulla. Apoptosis was much more evident in middle-dose groups (i.e., 125 and 300 mg/kg). The results of RT-PCR indicated that Bcl-2 and Bax mRNAs upregulated in the treated groups (p < 0.05). Moreover, the data related to EGF, TNF-α, and TGF-β1 revealed that AgNPs induced significant changes in gene expression in the groups treated with 30 and 700 mg/kg compared to the control group.

Conclusion: Our observations showed that AgNPs played a critical role in in vivo renal toxicity.

Keywords: Apoptosis; Kidney; Silver nanoparticles; Toxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Blood Urea Nitrogen
  • Body Weight / drug effects
  • Caspase 3 / metabolism
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / pathology
  • Creatinine / blood
  • Epidermal Growth Factor / genetics
  • Extracellular Matrix Proteins / genetics
  • Gene Expression
  • Immunohistochemistry
  • In Situ Nick-End Labeling
  • Kidney / drug effects
  • Kidney / pathology
  • Male
  • Metal Nanoparticles / toxicity*
  • Organ Size / drug effects
  • RNA, Messenger / genetics
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta / genetics
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Extracellular Matrix Proteins
  • RNA, Messenger
  • Transforming Growth Factor beta
  • Tumor Necrosis Factor-alpha
  • betaIG-H3 protein
  • Epidermal Growth Factor
  • Creatinine
  • Casp3 protein, rat
  • Caspase 3